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One of the biggest challenges in public health is the rising number of antibiotic
resistant pathogens and the lack of novel antibiotics. In recent years there is a
rising focus on fungi as sources of antimicrobial compounds due to their ability to
produce a large variety of bioactive compounds and the observation that virtually every
fungus may still contain yet unknown so called “cryptic,” often silenced, compounds.
These putative metabolites could include novel bioactive compounds. Considerable
effort is spent on methods to induce production of these “cryptic” metabolites. One
approach is the use of small molecule effectors, potentially influencing chromatin
landscape in fungi. We observed that the supernatant of the fungus Doratomyces
(D.) microsporus treated with valproic acid (VPA) displayed antimicrobial activity against
Staphylococcus (S.) aureus and two methicillin resistant clinical S. aureus isolates. VPA
treatment resulted in enhanced production of seven antimicrobial compounds: cyclo-
(L-proline-L-methionine) (cPM), p-hydroxybenzaldehyde, cyclo-(phenylalanine-proline)
(cFP), indole-3-carboxylic acid, phenylacetic acid (PAA) and indole-3-acetic acid. The
production of the antimicrobial compound phenyllactic acid was exclusively detectable
after VPA treatment. Furthermore three compounds, cPM, cFP, and PAA, were able to
boost the antimicrobial activity of other antimicrobial compounds. cPM, for the first time
isolated from fungi, and to a lesser extent PAA, are even able to decrease the minimal
inhibitory concentration of ampicillin in MRSA strains. In conclusion we could show in
this study that VPA treatment is a potent tool for induction of “cryptic” antimicrobial
compound production in fungi, and that the induced compounds are not exclusively
linked to the secondary metabolism. Furthermore this is the first discovery of the
rare diketopiperazine cPM in fungi. Additionally we could demonstrate that cPM and
PAA boost antibiotic activity against antibiotic resistant strains, suggesting a possible
application in combinatorial antibiotic treatment against resistant pathogens.
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INTRODUCTION
One of the biggest challenges in healthcare today is the rising
number of antibiotic resistant pathogenic microorganisms
isolated from human and veterinary sources and the lack of
novel antimicrobial agents in the discovery pipeline (Garcia-
Alvarez et al., 2012). This has reignited the interest in the
search of antimicrobial compounds derived from natural sources
(Ling et al., 2015). Fungi have gained great attention as
source of antimicrobial agents due to their ability to produce
a large variety of bioactive compounds and the observation
that virtually every fungus may still contain yet unknown so
called “cryptic,” often silenced, compounds (Keller et al., 2005).
The fungus Doratomyces (D.) microsporus is a member of the
Microascales family and is closely related to Scopulariopsis spp.,
which is known to produce the potent antimicrobial agent
deacetoxycephalosporin C (Webber et al., 1969). D. microsporus
is a worldwide distributed fungus mainly isolated from feces
but also from rotting plant material and soil, which has been
associated with decay (Domsch et al., 2007). It is known to
produce an extracellular keratinase, which is closely related to
proteinase K (Vignardet et al., 1999; Gradisar et al., 2000).
Furthermore it has been shown that this fungus has the ability
to degrade the antifungal alkaloid sampangine (Orabi et al.,
1999). Besides these studies little is known about the primary and
secondary metabolite profile of this fungus.
In fungi the expression and production of natural products,
including antimicrobial products, is either part of the primary
metabolism and/or the secondary metabolism. The primary
metabolism comprises compounds which are essential for the
growth of the fungus and the secondary metabolism includes
compounds not essential for the survival of the fungus, but
holding a competitive advantage in the respective habitat. In
fungi the secondary metabolite related genes are often physically
linked, forming so-called gene clusters, and expression is strongly
influenced by biotic and abiotic environmental factors (Shwab
et al., 2007). Thus “cryptic” compounds may not have been
identified in previous antimicrobial activity screens due to the
complex pattern of biotic and abiotic factors necessary to induce
the production of these compounds. Under standard laboratory
conditions the secondary metabolism related gene clusters are
often transcriptionally silenced, which has been linked to the
formation of facultative heterochromatin. The switch between
transcriptional silenced heterochromatin and active euchromatin
is accomplished by reversible chemical modifications of histones
(Wu and Grunstein, 2000; Hayes and Hansen, 2001). Activation
of transcription is mainly linked to acetylation of histones
which is performed by histone acetyltransferases (HATs) while
deacetylation, carried out by histone deacetylases (HDACs), is
known to generally decrease secondary metabolite levels by the
formation of heterochromatin (Csordas, 1990; Brownell and
Allis, 1996; Strauss and Reyes-Dominguez, 2011; Gacek and
Strauss, 2012). Recently, the ability of small molecule effectors,
like valproic acid (VPA), to inhibit the catalytic activity of
HDACs and to modulate the subsequent “cryptic” expression
profile of secondary metabolites has been shown in fungi (Shwab
et al., 2007; Cole, 2008; Cichewicz, 2010; Hagemann et al., 2011).
TABLE 1 | Strains used in this study.
Species Strain Source
Staphylococcus (S.) aureus ATCC 6538 Human
Pseudomonas (P.) aeruginosa ATCC 9027 Human
Candida (C.) albicans ATCC 10231 Human
Klebsiella (K.) pneumoniae ATCC 13883 Human
Escherichia (E.) coli Roche3943B (MC
1061)
Human
Staphylococcus (S.) epidermidis ATCC 12228 Human (skin)
Enterococcus (E.) faecium DSMZ 13589 Human (faces)
Enterococcus (E.) faecalis ATCC 29212 Human (urine)
Streptococcus (S.) pneumoniae DSMZ 11865 Human
Clostridium (C.) difficile DSMZ 1296 Human (feaces)
Listeria (L.) monocytogenes ATCC BAA-679
(EGDe)
Rabbit
Streptococcus (S.) suis HK47 Human
Bacillus (B.) cereus (isolate) HK48 Food
ESBL Klebsiella (K.) pneumoniae B100173 Human
ESBL Escherichia (E.) coli B300129 Human
MRSA Staphylococcus (S.) aureus B337919 Human
MRSA Staphylococcus (S.) aureus B335466 Human
Furthermore our previous study suggests that the effect of VPA
seems to be target specific in fungi (Zutz et al., 2013).
In a previous work we have established a screening system
based on the use of such low molecular weight molecules,
like VPA, to induce the production of “cryptic” antimicrobial
compounds in fungi (Zutz et al., 2014). In this work we focused
on one hit candidate, the fungus D. microsporus, which displayed
antimicrobial activity exclusively after VPA treatment. In the
current study we identified and characterized the “cryptic”
antimicrobial active compounds of the fungus D. microsporus
after induction by VPA treatment. We report the identification of
seven induced antimicrobial compounds derived from primary
and secondary metabolism of the fungus, including cyclo-(L-
proline-L-methionine), which was for the first time discovered in
fungi. Thus the results indicate that VPA is a potent tool to induce
antimicrobial compound production.
MATERIALS AND METHODS
Strains and Chemicals
The D. microsporus isolate used in this study originated from
soil and was obtained from the fungal strain collection of the
AIT (Austrian Institute of Technology, Fungal Genetics and
Genomics Unit). Identification of the fungus was performed
according to Klaubauf et al. (2010). Bacterial strains used in
this study are listed in Table 1. The extended-spectrum beta-
lactamase (ESBL) Klebsiella (K.) pneumoniae (B100173) isolate
is resistant to the β-lactam antibiotics Ampicillin, Amoxicillin
and Piperacillin, the cephalosporins Cefotaxim and Ceftazidim,
the aminoglycoside antibiotics Gentamicin and Tobramycin,
the monobactam antibiotic Aztreonam, the tetracyclines,
sulfamethoxazole-trimethoprim, the fluoroquinolones and
Chloramphenicol. The ESBL Escherichia (E.) coli (B300129)
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isolate is resistant to the β-lactam antibiotics Ampicillin,
Amoxicillin, and Piperacillin, the cephalosporins Cefotaxim
and Ceftazidim, the aminoglycoside antibiotic Tobramycin,
the monobactam antibiotic Aztreonam, the flouroquinolones,
the tetracyclines and sulfamethoxazole-trimethoprim. The
methicillin-resistant Staphylococcus (S.) aureus isolate (MRSA)
B337919 is resistant to β-lactam antibiotics, the macrolides
Azithromycin and Erythromycin and the isolate B335466 was
resistant to β-lactam antibiotics and the fluoroquinolones
Enrofloxacin, Marbofloxacin and Ciprofloxacin (all resistant
strains were kindly provided by Analyze Biolab GmbH, Austria).
VPA was obtained from Sigma Aldrich (Germany) and prepared
as recently described (Zutz et al., 2013). 5-acetamidopentanoic
acid was obtained from Vitas-M laboratory (USA), the
diketopiperazines cyclo-(L-proline-L-methionine) and cyclo-(L-
phenylalanine-L-proline) were obtained from APARA Bioscience
(Germany). The chemicals p-hydroxybenzaldehyde, phenyllactic
acid, indole-3-carboxylic acid and indole-3-acetic acid were
obtained from Sigma–Aldrich (Germany) and phenylacetic acid
(PAA) from Merck (Germany).
Preparation of Fungal Extract
The fungal strain was inoculated on malt extract agar (MEA;
Oxoid, USA) and incubated at room temperature. Spores were
harvested after 10 days of incubation and inoculated in 20 ml
minimal fungal media at a concentration of 106 spores/ml (Moser
media, composed of 10 g/l glucose, 0.2 g/l yeast extract, 2 g/l
tryptic-digested peptone from casein, 0.5 g/l KH2PO4, 50 mg/l
inositol, 75 mg/l CaCl2, 10 mg/l FeCl3, 150 mg/l MgSO4, 10 mg/l
MnSO4). Tryptophan (Trp) was added at a concentration of
2 × 103 µM. VPA was added at a final concentration of 50 µM.
The fungal culture was incubated for 72 h at room temperature
on a rotary shaker at 180 rpm. After incubation the supernatant
was filtered through a cellulose filter and was extracted twice with
ethylacetate 1:1 (v/v). The ethylacetate phases were pooled and
dried under reduced pressure and stored at −20◦C. For isolation
of compounds in total 100 liters of fungal culture were prepared
in 50 2-l cultures under identical conditions and extracted.
Assessment of Antimicrobial Activity
The antimicrobial activity testing was performed as previously
described (Zutz et al., 2014). Additionally to the indicator
organisms S. aureus, Candida (C.) albicans and Pseudomonas
(P.) aeruginosa we used also Klebsiella (K.) pneumoniae,
Staphylococcus (S.) epidermidis, Enterococcus (E.) faecium,
Enterococcus (E.) faecalis, Streptococcus (S.) pneumoniae,
Streptococcus (S.) suis, Clostridium (C.) difficile, Listeria (L.)
monocytogenes, Bacillus (B.) cereus, E. coli, ESBL Klebsiella
(K.) pneumoniae, ESBL Escherichia (E.) coli and two MRSA
Staphylococcus (S.) aureus (MRSA 335466, MRSA 337919). As
control we used the indicator organisms without the fungal
culture.
Stability of antimicrobial activity was assessed after proteinase
K digestion and heat treatment. Proteinase K digestion
was performed by incubating the fungal extract either with
1 × 105 µg/l proteinase K at 37◦C for 1 week or incubating the
extract with 1 × 106 µg/l proteinase K at 37◦C for 24 h. Heat
stability was assessed after incubation of the fungal extract at
95◦C for 24 h.
Cell Viability Assay
The effect of the fungal extract on the viability of the indicator
organisms S. aureus and P. aeruginosa was determined using a cell
staining assay (LIVE/DEAD BacLight Invitrogen). Samples were
taken after 0, 6, and 18 h of incubation. Each sample was diluted
with Fresenius Ringer 1000-fold. The filters were assembled
according to manufacturer’s protocol (Swinnex Millipore). Each
assembly consisted of a cellulose acetate membrane filter and
a polycarbonate membrane filter (Sterlitech). The filters were
equilibrated with 1 ml of Fresenius Ringer solution for 30 min
at room temperature prior to use. The fluorescence probes
propidium iodide and syto 9 were prepared according to
manufacturer’s protocol. After mixing the probes with the
indicator organisms, the mixture was incubated for 20 min in the
absence of light at room temperature. Following the incubation
step the suspension was diluted with Fresenius Ringer solution
in a ratio of 1:0.8 and pressed through the filters. Examination
was performed using a confocal laser scanning microscope (510
Meta, ZEISS; syto 9 excitation at 488 nm and emission at 505–
530 longpass filter and propidium iodide excitation at 543 nm
and emission at 610–640 longpass filter). For Syto9 the following
parameters were used: pinhole 2 µm, laser gain 771–800, digital
offset at −0.07, laser intensity at 5% and digital gain at 1. For
propidium iodide the parameters were pinhole 2 µm, laser gain
540–600, digital offset at −0.07, laser intensity at 10% and digital
gain at 1. Image analysis was performed using ImageJ (Schneider
et al., 2012) and the Zen software (Zeiss). As control we used the
indicator strains without addition of the fungal culture.
Cytotoxicity Assay
Cytotoxicity of the fungal extract and the identified compounds
was determined measuring lactate dehydrogenase release using
human intestinal epithelial (Caco2) and human hepatocytic
(HepG2) cells. Briefly, cells were cultivated using Eagle’s
minimum essential media (MEM) supplemented with 2 mM
L-glutamine, 10% fetal bovine serum (FBS), 1 × 105 Units/l
penicillin, 1 × 108 µg/l streptomycin sulfate, 2.5 × 106 µg/l
amphotericin B and 1% non-essential amino acids (NEAA; all
from PAA) at 37◦C in a humidified atmosphere (95% relative
humidity) containing 5% CO2. Cells were seeded into 96-well
plates (5 × 104 cells per well) and incubated until a confluent
cell layer had developed. After discarding of the media cells
were incubated with 50 µl of media and 50 µl of fungal extract
or compound (final concentration: PAA 2 × 106 µg/l, 4FP
2 × 106 µg/l, ICA 2 × 106 µg/l, IAA 2 × 105 µg/l, PLA
2 × 106 µg/l, cPM 2 × 106 µg/l and cFP 2 × 106 µg/l) for 24 h
at 37◦C. Media alone and VPA (50 µM) were taken as control.
LDH release was measured according to the manufacturer’s
protocol (Sigma–Aldrich, USA). The percentage of dead cells
was calculated using a standard curve of serial diluted lysed cells
(100% dead cells) as previously described (Zutz et al., 2014).
In parallel the % of metabolic cells was measured using
the XTT [2,3-Bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetra-
zolium-5-carboxanilide] assay (Thermo Scientific). Briefly, after
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treatment with the fungal extract or the different compounds
cells were incubated with XTT and phenanzine methosulfate
(Thermo Scientific) for 2 h. Absorbance was measured at 450 nm
and % of metabolic active cells was calculated versus the control
sample (media). As controls we incubated the cells without fungal
cultures or compound, and with VPA alone.
High Performance Liquid
Chromatography (HPLC)
The dried fungal extract was re-dissolved in methanol/water
(1:4) and fractionated on a preparative HPLC system (Agilent
1100 series) coupled with an ELSD (Sedex, Sedere 85 LT-ELSD,
3.1 bar nitrogen, 50◦C) using a Gemini NX, 5 µm C18, 110Å,
150 × 21.2 mm AXIA (Phenomenex, USA) column. Separation
was performed using a linear methanol/water gradient starting
at 20–40% methanol in 20 min followed by a cleaning time
of 4 min with 100% methanol at a flow rate of 20 ml min−1
with an injection volume of 1800 µl. Six pooled fractions of 53
individual separation runs, in total 630 ml per fraction, were
collected, evaporated and dissolved in methanol/water (1:1).
The antimicrobial active fractions were further separated on
the preparative HPLC system using a Gemini NX, 5 µm C18,
110Å, 150 × 21.2 mm AXIA column. An isocratic separation
was performed using acetonitrile/water (20:80) with 0.1% formic
acid for 10 min at a flow rate of 20 ml min−1. Absorbance
of fractions was measured at 210, 225, 250, and 300 nm.
Bioactive fractions were stored at −20◦C until further structure
elucidation.
Structure Elucidation
Structure elucidation of the isolated compounds was performed
using nuclear magnetic resonance (NMR, Supplementary Table
S3) and mass spectrometry (MS). NMR spectra were recorded
on a Bruker Avance II 400 (Bruker, Rheinstetten, Germany;
resonance frequencies 400.13 MHz for 1H and 100.61 MHz for
13C) equipped with a 5 mm observe broadband probe head
(BBFO) with z–gradients at room temperature with standard
Bruker pulse programs. The samples were dissolved in 0.6 ml
of methanol-d4 (euriso-top, 99.8% D). The MS measurements
were performed on an Orbitrap LTQ XL-MS (Thermo Scientific)
with HPLC (Thermo Scientific) and HTC-Pal autosampler (PAL
SYSTEM). Internal standards of purchased compounds were used
to confirm the presence and the amount of the compounds in the
fungal cultures.
Determination of MIC
Minimal inhibitory concentrations (MICs) of purified
compounds and commercially available standards were assessed
against S. aureus, C. albicans, P. aeruginosa, K. pneumoniae,
E. coli, ESBL K. pneumoniae, ESBL E. coli and the two MRSA
strains (B337919 and B335466). Stock solutions of 5 × 106 µg/l
of p-hydroxybenzaldehyde, and phenyllactic acid were prepared
using water. Stock solutions of 1 × 108 µg/l indole-3-carboxylic
acid, PAA and indole-3-acetic acid were prepared using methanol
and diluted with water (working solution of 5× 106 µg/l). Stocks
of 1 × 106 µg/l of cFP and cPM were dissolved in water.
Concentrations of 5 × 106, 2.5 × 106, 2 × 106, 1.5 × 106,
1 × 106, 5 × 105, 2.5 × 105, 2 × 105, 1 × 105, 5 × 104,
1 × 104 µg/l were used for MIC determination. Methanol and
water were used as control.
FIGURE 1 | Antimicrobial effect of the supernatant of valproic acid
treated D. microsporus on S. aureus. Effect of the supernatant of
untreated (−VPA) and VPA treated (+VPA) D. microsporus on growth [OD600,
(A)] and log10 CFU reduction (B) and percentage of dead cells (C) of
S. aureus measured after 0, 6, and 18 h of incubation at 37◦C. Control
comprises of S. aureus cells grown without fungal extract. Data are presented
as mean values ± standard deviations of three biological replicates performed
in triplicate. Asterisks indicate statistically significant difference compared to
the control (p < 0.05) according to student’s t-test.
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Analysis of Histone Posttranslational
Modifications by Western Blot
Mycelia from the D. microsporus cultures were harvested after
24, 48, and 72 h by filtration and frozen in liquid nitrogen.
Histones were extracted under acidic conditions as described
by Honda and Selker (2008). Samples were suspended in
Laemmli’s SDS sample buffer and quantified with Pierce BCA
Protein Assay (Thermo Scientific). Fifteen microgram of purified
histones were separated on 15% SDS-PAGE gel and subsequently
transferred to nitrocellulose membrane (GE Healthcare) by
electroblotting. Histone H3 acetylation (H3Ac) was detected
with primary antibody specific to H3Ac (Millipore, 06-599). As
a loading control histone H3 C-terminus was detected with
anti H3 C-terminus antibody (Abcam, 1791). The primary
antibodies were identified with anti- rabbit (Sigma–Aldrich,
A0545) horseradish peroxidase (HRP) conjugated secondary
antibody. Chemiluminescence was detected with ClarityTM ECL
Western Substrate and ChemiDocTM XRS (Bio- Rad).
RESULTS
Antimicrobial Activity of D. microsporus
The supernatants of the VPA treated D. microsporus cultures
showed a strong antimicrobial activity against S. aureus
(Figure 1A) and the MRSA strains B337919 and B335466
whereas the untreated fungal extracts displayed no antimicrobial
activity. The active fungal extracts showed a log10 growth
reduction of 3.7–4 log units for S. aureus after 6 h of incubation
(Figure 1B). Furthermore a log reduction of 3.3–3.6 log units
against both MRSA strains was observed. Weak activity was
observed against E. coli, ESBL E. coli and K. pneumoniae
TABLE 2 | Antimicrobial activity of fungal extracts.
Growth inhibitiona
Strain 6 h 18 h
S.aureus +++ ++
MRSA 337 ++ ++
MRSA 335 ++ ++
P. aeruginosa − −
C. albicans − −
E. coli + −
ESBL E. coli + –
K. pneumoniae + +
ESBL K.
pneumoniae
− −
L. monocytogenes − −
E. faecalis − −
E. faecium − −
B. cereus − −
S. epidermidis − −
S. suis + −
S. pneumoniae − −
aGrowth inhibition was graded as follows: (+++) no measurable growth, (++)
more than half growth reduction compared to control, (+) less than half reduction
compared to control, (−) no significant reduction compared to control. Control
comprises growth of test organism in the presence of supernatant of untreated
fungus.
(Table 2). The cell viability assay (LIVE/DEAD) revealed that
the VPA treated fungal extracts led to 30% of dead cells after
6 h of incubation which indicated a bacteriostatic activity
of the fungal culture (Figure 1C). To further characterize
the antibacterial compound(s) in the extracts we determined
FIGURE 2 | Cytotoxic effect of the supernatant of VPA treated (+VPA) and untreated (−VPA) D. microsporus on human intestinal epithelial Caco2 and
human hepatocytic HepG2 cells. Control comprises HepG2 and Caco2 cells incubated in media for 24 h, VPA control comprises cells incubated with media
containing VPA. Data, presented as percentage of dead cells, are mean values ± standard deviations of three biological replicates performed in triplicate.
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FIGURE 3 | High performance liquid chromatography (HPLC)-chromatogram of the EtOAc extract of the supernatant of VPA treated D. microspores.
Fraction 1 – 4 are antimicrobial active fractions.
proteinase K stability. The antimicrobial activity after incubation
with 1 × 105 µg/l for 24 h and with 1 × 106 µg/l proteinase K at
37◦C for 1 week (data not shown) (Supplementary Figure S1) was
unchanged. This indicated that the active compound(s) were not
proteins or peptides susceptible to proteinase K digestion. Heat
stability of the fungal extracts was assessed after incubation at
96◦C for 1 h. No significant reduction of bioactivity was observed
(data not shown).
Cytotoxicity of D. microsporus Extract
Observed cytotoxicity using the LDH assay was below 1%
of dead cells for Caco2 and HepG2 cells after 24 h which
is regarded as non-cytotoxic for the mixture of unknown
compounds (Figure 2). Overall we detected a lower cytotoxicity
of cells incubated with the fungal cultures compared to the
media, indicating that the fungal extracts contain compounds
supporting the survival of human cells. VPA alone did
not increase cytotoxicity compared to the media alone. The
percentage of metabolic active cells measured with the XTT assay
showed corresponding high rates (Supplementary Figure S2).
Purification and Characterization of
Compounds
Bioactivity driven fractionation revealed that the antimicrobial
activity was recovered in the ethylacetate phase of the VPA
treated fungal culture after liquid extraction. Further separation
of the ethylacetate phase on a preparative reversed phase
HPLC system using a C18 column and methanol as solvent
resulted in the identification of four antimicrobial active
fractions termed Fraction 1–4 (Figure 3). All fractions displaying
antimicrobial activity were further separated using the C18
column and acetonitrile supplemented with 0.1% formic
acid. Three compounds of fraction 1 could be identified:
N-(5-hydroxypentyl)acetamide (1.1), 5-acetamidopentanoic
acid (1.2) and 3-hydroxy-3-methylbutanamide (1.3); two
compounds of fraction 2: diketopiperazine cyclo-(L-proline-
L-methionine) (cPM, 2.1) and p-hydroxybenzaldehyde (4FP,
2.2); one compound of fraction 3: phenyllactic acid (PLA;
3.1) and four compounds of fraction 4: the diketopiperazine
cyclo-(L-phenylalanine-L-proline) (cFP, 4.1), indole-3-carboxylic
acid (ICA, 4.2), PAA (4.3) and indole-3-acetic acid (IAA,
4.4). Compound identification was based on NMR structure
elucidation and confirmed by MS using internal standards
(Supplementary Table S1). Additionally we confirmed the
presence of the identified compounds in the crude fungal
culture. Figure 4 shows the structure formulas of the 10 isolated
compounds.
Determination of MICs
In total seven compounds showed an inhibitory effect on
microbial growth. Generally, accepted MIC values for antibiotics
in clinical use range from 0.003 (for levofloxacin) to 100 mg/l (for
co-trimoxazole). However, in research MIC values for antibiotics
are tested up to a concentration of 1 g/l (Rodloff et al., 2008).
Thus the threshold for considering a compound as being
antimicrobial was set to MIC < 5 g/l. S. aureus showed
susceptibility to IAA (MIC: 400 mg/l), which was also displayed
by the MRSA strain B335466. However, the MRSA strain
B337919 was more susceptible showing a MIC of 200 mg/l. IAA
displayed also strong antimicrobial activity against C. albicans
(MIC: 400 mg/l) (Table 3). The isolated diketopiperazines
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FIGURE 4 | Compounds isolated from the supernatant of the VPA treated D. microsporus culture. Numbers indicate the corresponding fraction and peak
of the isolated compounds.
showed inhibitory activity on the growth of all tested organisms.
Since MIC values were higher than 5 g/l we determined the lowest
concentrations at which the inhibitory effect was detectable
(Table 4).
Influence of VPA
As VPA is thought to boost production of secondary metabolites
through inhibition of histone deacetylases, we determined
acetylation levels of histone H3 K9 and K14 of VPA-treated and
control cultures. However, we could not detect any significant
increase in acetylation of the N-terminal lysines of histone
3 compared to the untreated control culture (Supplementary
Figure S3). This suggests that either VPA does not increase
histone acetylation in D. microsporus or that the chromatin effect
is locus-specific and can thus not be detected by the applied
method detecting only global changes in acetylation levels.
The influence of VPA on the production of the isolated
compounds was determined by MS using commercially available
standard compounds. It could be shown that VPA induces the
production of all isolated compounds. PLA was not detectable in
the untreated fungal culture, but VPA treatment resulted in the
production of 0.07 mg/l PLA.
Two of the isolated compounds (IAA and ICA) contain indole
structures and could have genetic links to the fungal auxin
biosynthesis pathway in which Trp is used as main substrate
(Maor et al., 2004). Therefore we determined the influence of Trp
alone and in combination with VPA on the production of the
seven antimicrobial compounds (Table 5). Trp addition to media
showed increased production of all indole related compounds.
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TABLE 3 | Minimal inhibitory concentration (MIC) values of isolated
compounds.
Strain MIC [g/l]
PAA 4FP IAA PLA ICA
S. aureus 2 2 0.4 2 2
MRSA 337 2 2.5 0.2 2 2
MRSA 335 2 2.5 0.4 2 2
P. aeruginosa n.d. 2.5 2 5 2
C. albicans 2.5 1 0.4 n.d. n.d.
E. coli 2 2.5 1.75 2.5 1
ESBL E. coli 2 2.5 1.75 5 1
K. pneumoniae 2.5 2.5 0.4 2.5 2
ESBL K. pneumoniae 2.5 2.5 2 5 2
n.d, not determinable.
TABLE 4 | Inhibitory concentrations of isolated diketopiperazines.
Strain Inhibitory concentration [g/l]
cFP cPM
S. aureus 2 2.5
MRSA 337 2 2.5
MRSA 335 2 2.5
P. aeruginosa 5 5
C. albicans 2.5 5
E. coli 5 5
ESBL E. coli 5 5
K. pneumoniae 3 5
ESBL K. pneumoniae 3 5
The production of IAA, the final product of the biosynthesis
pathway, was increased up to 43-fold. The combination of Trp
and VPA lead to a further increase of the IAA production (57-
fold) compared to the untreated culture. The production of
both diketopiperazines and PLA were not influenced by Trp. In
addition, the concentration of PAA decreased compared to VPA
treated culture if Trp was used during cultivation indicating that
Trp may be an inhibitor of the PAA biosynthetic pathway.
Cytotoxicity of Isolated Compounds
Cytotoxicity of all purified compounds was determined using
the determined MIC concentrations. PAA, ICA, cPM and
cFP showed low toxicity (3.99–8.61% dead cells). Moderate
cytotoxicity was displayed by 4FP against Caco2 cells (25.9%
dead cells); in parallel the rate of metabolic active cells decreased
compared to the control (57.3% metabolic active cells). PLA
showed moderate cytotoxicity against the Caco2 cells (19.7%
dead cells) and elevated cytotoxicity against HepG2 cells (54.63%
dead cells). Accordingly, the rate of metabolic active cells ranged
for both cell lines from 50 to 70% (Supplementary Table S2).
Combinatorial Effects
The effect of combinations of the identified compounds
(concentrations from 0.002 to 2 g/l) on the antimicrobial
activity was determined against S. aureus, P. aeruginosa and
C. albicans (Supplementary Table S3). The combination of
PAA and PLA decreased the MIC value to 1 g/l against
S. aureus (Figure 5A). The antimicrobial activity of PLA was
additionally increased in the presence of the diketopiperazine
cPM (Figure 5B). All antimicrobial active compounds except
cPM and cFP showed increased antimicrobial activity
against S. aureus and P. aeruginosa if combined with PAA.
Combination of cPM, PAA and PLA lead to synergistic
increase of antimicrobial activity of PLA (Supplementary
Table S3).
Furthermore we studied the ability of PAA, cPM and cFP to
increase antimicrobial activity of ampicillin against both ESBL
and MRSA strains. The combination of cPM (100 mg/l) with
ampicillin decreased the MIC value from 100 to 10 mg/l against
the MRSA strain B335466 (Figure 5C). The combination of PAA
(1 g/l) and ampicillin showed a weak synergistic effect on the
MRSA strain B335466 decreasing the MIC from 100 to 50 mg/l.
Additionally the MRSA strain B337919 was less susceptible to the
synergistic activity of cPM (2 g/l) and ampicillin which resulted
TABLE 5 | Concentrations of compounds isolated from the supernatant of untreated, VPA treated (+VPA), tryptophan treated (+Trp) and VPA and
tryptophan (VPA+Trp) treated D. microspores.
Compound Amount [mg/l] x-fold of untreated extract
Untreated +VPA +Trp VPA + Trp +VPA +Trp VPA + Trp
PAA 0.08 0.60 0.16 0.39 7.5 2.38 4.875
4FP 0.04 0.05 0.04 0.04 1.25 1 1
IAA 0.01 0.08 0.43 0.57 8 43 57
PLA n.d. 0.07 n.d. n.d. n.d. n.d. n.d.
cPM 0.02 0.07 0.02 0.04 3.5 1 2
ICA 0.01 0.05 0.17 0.17 5 17 17
cFP 0.0008 0.0040 0.0007 0.0011 5 0.875 1.375
5-acetamido pentanoic acid n.d. 0.02 n.d. n.d. n.d. n.d. n.d.
N-(5 hydroxy pentyl)acetamide n.d. 0.01 n.d. n.d. n.d. n.d. n.d.
3-hydroxy-3-methylbutanamide n.d. 0.004 n.d. n.d. n.d. n.d. n.d.
n.d., not detectable.
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FIGURE 5 | Effect of combined compounds on antimicrobial activity.
Effect of PLA (0.5 g/l) and PAA (1 g/l) alone and combined (A), and effect of
the diketopiperazine cPM (1 g/l) and PLA (0.5 g/l) alone and combined (B) on
the growth of S. aureus. (C) Effect of ampicillin (10 mg/l) and cPM (100 mg/l)
alone and combined on the growth of S. aureus MRSA strain B335466. Data
are presented as mean values ± standard deviations of three biological
replicates performed in triplicate.
in a decrease of MIC value from 100 to 50 mg/l. No synergistic
or additive effect was observed against the ESBL E. coli strain and
the ESBL K. pneumoniae strain (Supplementary Table S3).
DISCUSSION
Recent studies have shown that small molecule effectors like VPA
are able to induce “cryptic” secondary metabolite production in
fungi (Shwab et al., 2007; Cole, 2008; Cichewicz, 2010). The ability
of VPA to induce antimicrobial activity in a broad range of fungi
and to trigger the expression of secondary metabolite related
polyketide synthases has been shown by our group before (Zutz
et al., 2013, 2014). Thus, the goal of this study was to identify
the “cryptic” antimicrobial compounds underlying the activity
observed in the VPA treated fungal culture of D. microsporus.
However, if the induction of antimicrobial activity is linked to
the ability of VPA to modulate chromatin structure or other
effects remains to be clarified. To better describe the influence of
VPA on the production of “cryptic” antimicrobial compounds,
VPA treated fungal culture were used for bioactivity driven
fractionation.
Seven “cryptic” antimicrobial active compounds could be
isolated (PAA, 4FP, IAA, PLA, cPM, ICA and cFP). Interestingly
all isolated compounds except the two diketopiperazines are
associated with the primary metabolism of fungi. PAA, ICA
and IAA are phytohormones (Gustafson, 1941; Anaya et al.,
1992). This indicates that the habitat of the fungus may not
only be linked to decaying plant material and feces, but that
this fungus could have the potential to infest plants. During the
growth of plants a complex pattern of auxin-related compounds
like IAA and ICA regulates physiological and developmental
processes. There are suggestions that PAA is linked also to the
auxin biosynthesis pathway. In Azospirillum brasilense it has
been shown that the PAA synthesis is mediated by the indole-3-
pyruvate decarboxylase (IpdC), a key enzyme of IAA production
(Somers et al., 2005). PAA furthermore increased like IAA and
other auxins the expression of the ipdC gene (Somers et al., 2005).
There is evidence that the cohabitation of fungi and bacteria
(either endophytic or symbiotic) influence the production of
these compounds in the plant. This can also lead to tumor or
gall formation (Ditengou and Lapeyrie, 2000; Vasanthakumar
and McManus, 2004; Reineke et al., 2008; Xin et al., 2009;
Zuniga et al., 2013; Duca et al., 2014). ICA has been shown
to be part of the priming response of higher plants to the
infestation of Plectosphaerella cucumerina (Gamir et al., 2012). In
the plant pathogenic/saprophytic fungus Rhizoctonia solani the
PAA production has been identified as major component for the
virulence of the fungus (Mandava et al., 1980). Trp is known to be
one of the main substrates for the IAA biosynthesis pathway in
plants (Magnus et al., 1982). Thus we investigated the influence
of Trp alone and in combination with VPA on the production
of the indole related compounds identified in this study. Trp
doubles the production of IAA and ICA. These data suggest that
a functional indole biosynthesis pathway may be present in the
fungus.
Another strong indication for the potential ability of
D. microsporus to infest plants is the production of 4FP, which
was slightly increased if the fungus was treated with VPA. 4FP is
known as phytotoxic metabolite of fungi and has been isolated
from Discula quercina and Ceratocystis spp. Additionally 4FP
has been identified together with PAA as a major phytotoxic
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compound produced by the fungus Monilia sp. (Ayer et al., 1986;
Maddau et al., 2011).
Phenyllactic acid, originally isolated from bacteria, has so
far only been detected in one fungus, Geotrichum candidum,
which is used as biocontrol agent in cheese ripening (Dieuleveux
et al., 1998). Geotrichum candidum is also able to produce
IAA. In this study PLA is the only compound which was not
detectable in the untreated fungal culture. Thus VPA increased
the production of an otherwise silent antimicrobial “cryptic”
compound. In a recent study the influence of aromatic amino
acids including Trp on the production of PLA and IAA in
Geotrichum candidum was investigated (Naz et al., 2013). It has
been shown that Trp addition increased the production of PLA
and IAA. However, in D. microsporus Trp showed no measurable
effect on PLA production. The observation that Trp does not
increase production of PLA but of IAA considerably indicates
that either PLA is linked to a different biosynthesis pathway in
D. microsporus or that the amount of produced PLA is below the
limit of detection.
The majority of isolated compounds derived from the
primary metabolism. These compounds have been secreted (or
leaked) into the media. Secretion of metabolites is linked to
many biological functions like influencing the auxin levels of
the host and disrupting of quorum sensing signals. Secreted
metabolites are known to be main players in the complex
growth interactions of microorganisms. The variety of discovered
bioactive metabolites indicates a potentially larger number of
secreted metabolites yet to be discovered.
Seven “cryptic” antimicrobial compounds were isolated in
the mg/l range. Although the MIC values of the respective
compounds ranged from 0.4 to 5 g/l we observed a strong
antimicrobial activity of the VPA treated fungal culture. This
indicates that the cocktail of all seven compounds was responsible
for the observed antimicrobial activity.
The most abundant compound was PAA which was produced
in almost 10-fold higher concentration under VPA treatment.
PAA is produced by fungi and bacteria (Mayrand, 1979; Mayrand
and Bourgeau, 1982; Ait Kettout and Rahmania, 2010) and has
been linked to antifungal and antibacterial activity against a broad
range of microorganisms including S. aureus, K. pneumoniae, P.
aeruginosa, and L. monocytogenes (Hwang et al., 2001; Kim et al.,
2004; Slininger et al., 2004). In P. aeruginosa it has also been
shown to inhibit quorum sensing (Musthafa et al., 2012).
Combination of ICA and IAA displayed increased activity
against S. aureus but not against P. aeruginosa. PAA lead to
an increase of antimicrobial activity of IAA, ICA, PLA and
4FP against S. aureus. This suggests that PAA could be able
to potentiate antimicrobial activity. However, combinations of
the indole related compounds, at the respective concentrations
discovered in the fungus, did not result in the observed
antimicrobial activity of the extracted fungal supernatants.
Additionally two diketopiperazines cFP and cPM were
isolated. Diketopiperazines are cyclic dipeptides described in
bacteria, which are mainly synthesized through non-ribosomal
peptide synthetases activity and to lesser extend through
cyclodipeptide synthases activity (Gu et al., 2013). Thus their
synthesis is linked to the secondary metabolism. cPM was
first and so far only isolated from an P. aeruginosa strain
associated with the antarctic sponge Isodictya setifera (Mottram
and Taylor, 2010; Neil et al., 2010). Previous characterizations of
this compound were associated with processed food. In this study
we demonstrated the first natural isolation of this rare compound
from a fungus. The cyclic dipeptide family contains several
bioactive compounds and they have been studied to determine
their antimicrobial activity (Kumar et al., 2014). Proline based
dipeptides are among the most potent cyclic dipeptides. The
production of both diketopiperazines was induced by VPA
treatment up to five fold. cFP, which is produced by bacteria and
fungi, is involved in quorum sensing in gram negative bacteria
(Holden et al., 2000). In the studies describing the first isolation
of cPM and cFP no antimicrobial activity of either against Bacillus
subtilis, S. aureus and Micrococcus luteus was reported (Jayatilake
et al., 1996; Thomas et al., 2010). However, antimicrobial activity
of cFP against higher fungi (MIC of 20 g/l) has been described
(Strom et al., 2002). In this study we could show that cPM is
antimicrobial active due to its growth inhibitory activity (2 g/l)
against the tested microorganisms.
The combination of the isolated antimicrobial compounds
with cPM and to lesser extent with cFP resulted in increased
antimicrobial activity of 4FP, IAA and PLA. Furthermore we
could show that cPM and to lesser extend PAA are able to enhance
ampicillin activity against two resistant MRSA strains decreasing
the MIC value to 10 mg/l. The ability of cPM to increase
antimicrobial activity of iminpenem has recently been shown
against a range of non-resistant medically important pathogens
(Kumar et al., 2014).
We concluded that the observed antimicrobial activity of the
VPA treated fungal culture against S. aureus is likely the result of
PAA, cPM and cFP potentiating the activity of IAA, ICA, PLA
and 4FP together with the additional effect of all compounds.
CONCLUSION
We could show that VPA treatment is a potent tool for induction
of “cryptic” antimicrobial compound production in fungi and
that the induced compounds are not exclusively linked to the
secondary metabolism. Furthermore this is the first discovery
of the rare diketopiperazine cPM in fungi. Additionally we
could show that cPM and PAA have the ability to potentiate
antimicrobial activity of ampicillin against ampicillin resistant
pathogens. This ability combined with low cytotoxicity makes
cPM and to lesser extend PAA ideal candidates for combination
therapies against resistant pathogens.
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